VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
78 hedge funds and large institutions have $113M invested in Viracta Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less capital invested
Capital invested by funds: $380M → $113M (-$268M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
78
Holding in Top 10
–
Calls
$1.81M
Puts
$903K
Top Buyers
| 1 | +$8.16M | |
| 2 | +$8M | |
| 3 | +$5.65M | |
| 4 |
First Eagle Investment Management
New York
|
+$3.61M |
| 5 |
Morgan Stanley
New York
|
+$2.5M |
Top Sellers
| 1 | -$34.8M | |
| 2 | -$16.7M | |
| 3 | -$9.84M | |
| 4 |
LCP
Lamond Capital Partners
San Francisco,
California
|
-$9.43M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$9.38M |